Related references
Note: Only part of the references are listed.An iminosugar with potent inhibition of dengue virus infection in vivo
Stuart T. Perry et al.
ANTIVIRAL RESEARCH (2013)
Expression of functionally active sialylated human erythropoietin in plants
Jakub Jez et al.
BIOTECHNOLOGY JOURNAL (2013)
The development of synthetic antitumour vaccines from mucin glycopeptide antigens
Nikola Gaidzik et al.
CHEMICAL SOCIETY REVIEWS (2013)
The carbohydrate switch between pathogenic and immunosuppressive antigen-specific antibodies
Mattias Collin et al.
EXPERIMENTAL DERMATOLOGY (2013)
MUC1 immunotherapy is here to stay
Takashi Kimura et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Pichia pastoris: protein production host and model organism for biomedical research
Brigitte Gasser et al.
FUTURE MICROBIOLOGY (2013)
Dissecting the Molecular Mechanism of Mg Therapy: The Interaction between Serum IgG and DC-SIGN is Independent of Antibody Glycoform or Fc Domain
Xiaojie Yu et al.
JOURNAL OF MOLECULAR BIOLOGY (2013)
Antibodies expose multiple weaknesses in the glycan shield of HIV
Max Crispin et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120
Leopold Kong et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
N332-Directed Broadly Neutralizing Antibodies Use Diverse Modes of HIV-1 Recognition: Inferences from Heavy-Light Chain Complementation of Function
Marie Pancera et al.
PLOS ONE (2013)
Therapeutic potential of deglycosylated antibodies
Max Crispin
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Crystal structure of sialylated IgG Fc: Implications for the mechanism of intravenous immunoglobulin therapy
Max Crispin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
被撤回的出版物: Dominant suppression of inflammation by glycan-hydrolyzed IgG (Retracted article. See vol. 111, pg. 15851, 2014)
Kutty Selva Nandakumar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
SGK196 Is a Glycosylation-Specific O-Mannose Kinase Required for Dystroglycan Function
Takako Yoshida-Moriguchi et al.
SCIENCE (2013)
Carbohydrates and T cells: A sweet twosome
Fikri Y. Avci et al.
SEMINARS IN IMMUNOLOGY (2013)
Glycolipid antigens and autoantibodies in autoimmune neuropathies
Hugh J. Willison et al.
TRENDS IN IMMUNOLOGY (2013)
Emerging Technologies for Making Glycan-Defined Glycoproteins
Lai-Xi Wang et al.
ACS CHEMICAL BIOLOGY (2012)
Enzyme Replacement Therapy for Lysosomal Diseases: Lessons from 20 Years of Experience and Remaining Challenges
R. J. Desnick et al.
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 13 (2012)
IgG glycan hydrolysis by endoglycosidase S diminishes the proinflammatory properties of immune complexes from patients with systemic lupus erythematosus: A possible new treatment?
Christian Lood et al.
ARTHRITIS AND RHEUMATISM (2012)
Glycans as cancer biomarkers
Barbara Adamczyk et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Virtual ligand screening of α-glucosidase: Identification of a novel potent noncarbohydrate mimetic inhibitor
Wataru Hakamata et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation
Darius Ghaderi et al.
BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS VOL 28, ISSUE 1 (2012)
Regulation of the metastatic cell phenotype by sialylated glycans
Matthew J. Schultz et al.
CANCER AND METASTASIS REVIEWS (2012)
Host sialoglycans and bacterial sialidases: a mucosal perspective
Amanda L. Lewis et al.
CELLULAR MICROBIOLOGY (2012)
Pre-organization of the Core Structure of E-Selectin Antagonists
Daniel Schwizer et al.
CHEMISTRY-A EUROPEAN JOURNAL (2012)
Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy
L. G. Durrant et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)
Mechanisms of cancer-associated glycosylation changes
Fabio Dall'Olio et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2012)
Selective Deactivation of Serum IgG: A General Strategy for the Enhancement of Monoclonal Antibody Receptor Interactions
Kavitha Baruah et al.
JOURNAL OF MOLECULAR BIOLOGY (2012)
Chemical and Structural Analysis of an Antibody Folding Intermediate Trapped during Glycan Biosynthesis
Thomas A. Bowden et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
An Endoglycosidase with Alternative Glycan Specificity Allows Broadened Glycoprotein Remodelling
Jonathan J. Goodfellow et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Neurology of inherited glycosylation disorders
Hudson H. Freeze et al.
LANCET NEUROLOGY (2012)
Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine
Vani Lakshminarayanan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Human deficiencies of fucosylation and sialylation affecting selectin ligands
Kerstin Luehn et al.
SEMINARS IN IMMUNOPATHOLOGY (2012)
Microbial adhesins to gastrointestinal mucus
Nathalie Juge
TRENDS IN MICROBIOLOGY (2012)
Sialic acid,: a sweet swing between mammalian host and Trypanosoma cruzi
Leonardo Freire-de-Lima et al.
FRONTIERS IN IMMUNOLOGY (2012)
Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides - preclinical and clinical data
Ana M. Vazquezi et al.
FRONTIERS IN ONCOLOGY (2012)
Potential of Peptides as Inhibitors andMimotopes: Selection of Carbohydrate-Mimetic Peptides from Phage Display Libraries
Teruhiko Matsubara
JOURNAL OF NUCLEIC ACIDS (2012)
Broad neutralization coverage of HIV by multiple highly potent antibodies
Laura M. Walker et al.
NATURE (2011)
Phase III Multicenter Clinical Trial of the Sialyl-TN (STn)-Keyhole Limpet Hemocyanin (KLH) Vaccine for Metastatic Breast Cancer
David Miles et al.
ONCOLOGIST (2011)
Design of Glycopeptides Used to Investigate Class II MHC Binding and T-Cell Responses Associated with Autoimmune Arthritis
Ida E. Andersson et al.
PLOS ONE (2011)
The Glycan Shield of HIV Is Predominantly Oligomannose Independently of Production System or Viral Clade
Camille Bonomelli et al.
PLOS ONE (2011)
Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose
Claudia Ferrara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
Robert Pejchal et al.
SCIENCE (2011)
Cancer vaccines and carbohydrate epitopes
Jamie Heimburg-Molinaro et al.
VACCINE (2011)
The Hepatitis C Virus Glycan Shield and Evasion of the Humoral Immune Response
Francois Helle et al.
VIRUSES-BASEL (2011)
Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis
Haik Mkhikian et al.
NATURE COMMUNICATIONS (2011)
Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis
Ola Blixt et al.
BREAST CANCER RESEARCH (2011)
Tumor Antigen Epitopes Interpreted by the Immune System as Self or Abnormal-Self Differentially Affect Cancer Vaccine Responses
Sean O. Ryan et al.
CANCER RESEARCH (2010)
Polysaccharide mimicry of the epitope of the broadly neutralizing anti-HIV antibody, 2G12, induces enhanced antibody responses to self oligomannose glycans
D. Cameron Dunlop et al.
GLYCOBIOLOGY (2010)
Mice Producing Less Reactive Oxygen Species Are Relatively Resistant to Collagen Glycopeptide Vaccination against Arthritis
Tsvetelina Batsalova et al.
JOURNAL OF IMMUNOLOGY (2010)
Selectins promote tumor metastasis
Heinz Laeubli et al.
SEMINARS IN CANCER BIOLOGY (2010)
A Limited Number of Antibody Specificities Mediate Broad and Potent Serum Neutralization in Selected HIV-1 Infected Individuals
Laura M. Walker et al.
PLOS PATHOGENS (2010)
CDG nomenclature: Time for a change!
Jaak Jaeken et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Immunotherapy for cancer: synthetic carbohydrate-based vaccines
Therese Buskas et al.
CHEMICAL COMMUNICATIONS (2009)
Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics
Giancarlo Parenti
EMBO MOLECULAR MEDICINE (2009)
The use of agalsidase alfa enzyme replacement therapy in the treatment of Fabry disease
Chantal F. Morell et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Glycosylation in immune cell trafficking
Markus Sperandio et al.
IMMUNOLOGICAL REVIEWS (2009)
Carbohydrate and Domain Architecture of an Immature Antibody Glycoform Exhibiting Enhanced Effector Functions
Max Crispin et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
CANCER Inflaming metastasis
Alberto Mantovani
NATURE (2009)
The αGal HyperAcute® Technology: Enhancing Immunogenicity of Antiviral Vaccines by Exploiting the Natural αGal-Mediated Zoonotic Blockade
R. B. Mandell et al.
ZOONOSES AND PUBLIC HEALTH (2009)
N-Butyldeoxynojirimycin is a broadly effective anti-HIV therapy significantly enhanced by targeted liposome delivery
Stephanie Pollock et al.
AIDS (2008)
Anti-inflammatory actions of intravenous immunoglobulin
Falk Nimmerjahn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Getting in and out from calnexin/calreticulin cycles
Julio J. Caramelo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Mannose 6-phosphate receptor-mediated transport of sulfamidase across the blood-brain barrier in the newborn mouse
Akihiko Urayama et al.
MOLECULAR THERAPY (2008)
Cetuximab-induced anaphylaxis and IgE specific for galactose-α-1,3-galactose
Christine H. Chung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Aglycosylated immunoglobulin G1 variants productively engage activating Fc receptors
Stephen L. Sazinsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions
Mattias Collin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression
Maria Hedlund et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG fc
Robert M. Anthony et al.
SCIENCE (2008)
Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study
Marc C. Patterson et al.
LANCET NEUROLOGY (2007)
Mammalian N-glycan branching protects against innate immune self-recognition and inflammation in autoimmune disease pathogenesis
Ryan S. Green et al.
IMMUNITY (2007)
Effect of mannose chain length on targeting of glucocerebrosidase for enzyme replacement therapy of Gaucher disease
Scott M. Van Patten et al.
GLYCOBIOLOGY (2007)
Enhanced binding affinity for FcγRIIIa of fucose-negative antibody is sufficient to induce maximal antibody-dependent cellular cytotoxicity
Kazuhiro Masuda et al.
MOLECULAR IMMUNOLOGY (2007)
Heparan sulphate proteoglycans fine-tune mammalian physiology
Joseph R. Bishop et al.
NATURE (2007)
Exploiting the defensive sugars of HIV-1 for drug and vaccine design
Christopher N. Scanlan et al.
NATURE (2007)
Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types
Yutaka Kanda et al.
GLYCOBIOLOGY (2007)
Post-translational modifications in the context of therapeutic proteins
Gary Walsh et al.
NATURE BIOTECHNOLOGY (2006)
The iminosugar isofagomine increases the activity of N370S mutant acid β-glucosidase in Gaucher fibroblasts by several mechanisms
Richard A. Steet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Optimization of humanized IgGs in glycoengineered Pichia pastoris
HJ Li et al.
NATURE BIOTECHNOLOGY (2006)
The α-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy
U Galili
IMMUNOLOGY AND CELL BIOLOGY (2005)
Controlling influenza by inhibiting the virus's neuraminidase
E Garman et al.
CURRENT DRUG TARGETS (2004)
Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 Å
DM Zajonc et al.
NATURE IMMUNOLOGY (2003)
Antibody domain exchange is an immunological solution to carbohydrate cluster recognition
DA Calarese et al.
SCIENCE (2003)
Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity
S Krapp et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Glycosylation of erythropoietin affects receptor binding kinetics: Role of electrostatic interactions
RJ Darling et al.
BIOCHEMISTRY (2002)
Safety and efficacy of recombinant human α-galactosidase a replacement therapy in Fabry's disease.
CM Eng et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG
M Collin et al.
EMBO JOURNAL (2001)
Enzyme-replacement therapy in mucopolysaccharidosis I.
ED Kakkis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Resistance of native, oligomeric envelope on simian immunodeficiency virus to digestion by glycosidases
RE Means et al.
JOURNAL OF VIROLOGY (2000)
Discovery and development of GS 4104 (oseltamivir): An orally active influenza neuraminidase inhibitor
W Lew et al.
CURRENT MEDICINAL CHEMISTRY (2000)